Literature DB >> 23453819

ACCF/HRS/AHA/ASE/HFSA/SCAI/SCCT/SCMR 2013 appropriate use criteria for implantable cardioverter-defibrillators and cardiac resynchronization therapy: a report of the American College of Cardiology Foundation appropriate use criteria task force, Heart Rhythm Society, American Heart Association, American Society of Echocardiography, Heart Failure Society of America, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance.

Andrea M Russo, Raymond F Stainback, Steven R Bailey, Andrew E Epstein, Paul A Heidenreich, Mariell Jessup, Suraj Kapa, Mark S Kremers, Bruce D Lindsay, Lynne Warner Stevenson.   

Abstract

Entities:  

Mesh:

Year:  2013        PMID: 23453819     DOI: 10.1016/j.jacc.2012.12.017

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  88 in total

1.  Usefulness of a wearable cardioverter defibrillator combined with catheter ablation for ventricular tachyarrhythmia storms after a myocardial infarction: A case report.

Authors:  Yusuke Yoshikawa; Kazuaki Kaitani; Naoaki Onishi; Toshihiro Tamura; Chisato Izumi; Yoshihisa Nakagawa
Journal:  J Arrhythm       Date:  2015-02-16

2.  Predicting cardiac events using ventricular dyssynchrony in patients who received implantable cardioverter defibrillators: Are more treatment options required?

Authors:  Keiichiro Yoshinaga
Journal:  J Nucl Cardiol       Date:  2015-11-24       Impact factor: 5.952

3.  Cardiac fibrosis detected by magnetic resonance imaging on predicting time course diversity of left ventricular reverse remodeling in patients with idiopathic dilated cardiomyopathy.

Authors:  Yuki Ikeda; Takayuki Inomata; Teppei Fujita; Yuichiro Iida; Takeru Nabeta; Shunsuke Ishii; Emi Maekawa; Tomoyoshi Yanagisawa; Tomohiro Mizutani; Takashi Naruke; Toshimi Koitabashi; Ichiro Takeuchi; Junya Ako
Journal:  Heart Vessels       Date:  2016-02-03       Impact factor: 2.037

Review 4.  Sudden Cardiac Death Substrate Imaged by Magnetic Resonance Imaging: From Investigational Tool to Clinical Applications.

Authors:  Katherine C Wu
Journal:  Circ Cardiovasc Imaging       Date:  2017-07       Impact factor: 7.792

5.  [Lead survival and complications (except infections). Are we doing better nowadays?].

Authors:  Martin Seifert; Michael Neuss; Maren Schöpp; Cornel Koban; Christian Butter
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2013-08-06

Review 6.  Roles and indications for use of implantable defibrillator and resynchronization therapy in the prevention of sudden cardiac death in heart failure.

Authors:  Yitschak Biton; Jayson R Baman; Bronislava Polonsky
Journal:  Heart Fail Rev       Date:  2016-07       Impact factor: 4.214

7.  Rationale and design of a randomized trial to assess the safety and efficacy of MultiPoint Pacing (MPP) in cardiac resynchronization therapy: The MPP Trial.

Authors:  Gery Tomassoni; James Baker; Raffaele Corbisiero; Charles Love; David Martin; Robert Sheppard; Seth J Worley; Kwangdeok Lee; Imran Niazi
Journal:  Ann Noninvasive Electrocardiol       Date:  2017-05-18       Impact factor: 1.468

Review 8.  State-of-the-art narrative review: multimodality imaging in electrophysiology and cardiac device therapies.

Authors:  Balint Laczay; Divyang Patel; Richard Grimm; Bo Xu
Journal:  Cardiovasc Diagn Ther       Date:  2021-06

Review 9.  Arrhythmias in Patients ≥80 Years of Age: Pathophysiology, Management, and Outcomes.

Authors:  Anne B Curtis; Roshan Karki; Alexander Hattoum; Umesh C Sharma
Journal:  J Am Coll Cardiol       Date:  2018-05-08       Impact factor: 24.094

10.  Prognostic value of left ventricular mechanical dyssynchrony by phase analysis in patients with non-ischemic cardiomyopathy with ejection fraction 35-50% and QRS < 150 ms.

Authors:  Adam S Goldberg; M Chadi Alraies; Manuel D Cerqueira; Wael A Jaber; Wael A Aljaroudi
Journal:  J Nucl Cardiol       Date:  2013-10-04       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.